Larvol Delta - Altimmune-Announces-Initiation-of-RECLAIM-Phase-2-Trial-Evaluating-the-Efficacy-and-Safety-of-Pemvidutide-in-Alcohol-Use-Disorder-AUD

pemvidutide (ALT-801) - Altimmune

https://www.globenewswire.com/news-release/2025/05/19/3083911/0/en/Altimmune-Announces-Initiation-of-RECLAIM-Phase-2-Trial-Evaluating-the-Efficacy-and-Safety-of-Pemvidutide-in-Alcohol-Use-Disorder-AUD.html

May 19, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next